97: Converting from Paricalcitol Injection to Doxercalciferol Capsules in CKD Patients on HD: A Randomized, Open-Label Study to Determine Clinically Appropriate Doses

J. Hertel; S. Hariachar; A. Gonzalez

doi:10.1053/J.AJKD.2008.02.105

97: Converting from Paricalcitol Injection to Doxercalciferol Capsules in CKD Patients on HD: A Randomized, Open-Label Study to Determine Clinically Appropriate Doses

J. Hertel
, S. Hariachar
, A. Gonzalez

Nephrology Associates, Augusta GA
Outcomes Research International, Hudson, FL
Renal Endocrine Associates, P.C., Pittsburgh, PA

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	American Journal of Kidney Diseases
Volume	51
Issue number	4
DOIs	https://doi.org/10.1053/J.AJKD.2008.02.105
State	Published - Apr 1 2008
Externally published	Yes

Disciplines

Medicine and Health Sciences
Urology

Access to Document

10.1053/J.AJKD.2008.02.105License: Unspecified

Cite this

@article{3746c17dca874abe90a35f549e6b2eb2,

title = "97: Converting from Paricalcitol Injection to Doxercalciferol Capsules in CKD Patients on HD: A Randomized, Open-Label Study to Determine Clinically Appropriate Doses",

author = "J. Hertel and S. Hariachar and A. Gonzalez",

year = "2008",

month = apr,

day = "1",

doi = "10.1053/J.AJKD.2008.02.105",

language = "American English",

volume = "51",

journal = "American Journal of Kidney Diseases",

issn = "1523-6838",

number = "4",

}

TY - JOUR

T1 - 97: Converting from Paricalcitol Injection to Doxercalciferol Capsules in CKD Patients on HD: A Randomized, Open-Label Study to Determine Clinically Appropriate Doses

AU - Hertel, J.

AU - Hariachar, S.

AU - Gonzalez, A.

PY - 2008/4/1

Y1 - 2008/4/1

UR - https://www.ajkd.org/article/S0272-6386(08)00294-1/fulltext

U2 - 10.1053/J.AJKD.2008.02.105

DO - 10.1053/J.AJKD.2008.02.105

M3 - Article

SN - 1523-6838

VL - 51

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

IS - 4

ER -

97: Converting from Paricalcitol Injection to Doxercalciferol Capsules in CKD Patients on HD: A Randomized, Open-Label Study to Determine Clinically Appropriate Doses

Disciplines

Access to Document

Other files and links

Cite this